Correlation Between Evoke Pharma and Catalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Catalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Catalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Catalent, you can compare the effects of market volatilities on Evoke Pharma and Catalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Catalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Catalent.

Diversification Opportunities for Evoke Pharma and Catalent

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Evoke and Catalent is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Catalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalent and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Catalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalent has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Catalent go up and down completely randomly.

Pair Corralation between Evoke Pharma and Catalent

If you would invest (100.00) in Catalent on December 28, 2024 and sell it today you would earn a total of  100.00  from holding Catalent or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Evoke Pharma  vs.  Catalent

 Performance 
       Timeline  
Evoke Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Catalent 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Catalent has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Catalent is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Evoke Pharma and Catalent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evoke Pharma and Catalent

The main advantage of trading using opposite Evoke Pharma and Catalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Catalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will offset losses from the drop in Catalent's long position.
The idea behind Evoke Pharma and Catalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings